Denied and Delayed: How Insurance Barriers Are Costing Newark CJD Patients Precious Time
For families navigating a suspected CJD diagnosis in Newark, the medical system's complexity is compounded by a hidden adversary: insurance companies routinely denying coverage for the very tests that could confirm the disease earliest. This investigative report exposes how administrative roadblocks are accelerating disease progression for vulnerable patients — and what families can do to fight back.